CCL Featured Stories, Homepage Featured Stories, Resources, Special Communication
Changes to PARNEO, FTESTO
Special Communication
Changes to Test Build
Paraneoplastic Autoantibody Evaluation, Serum (PARNEO)
Effective September 5, 2019.
Interfaced Clients: These updates will require changes to the Test Build.
Test Discontinuation
Testosterone, Free and Total (FTESTO)
Effective August 29, 2019.
FTESTO will be made obsolete on August 29, 2019.
This test will be replaced with Testosterone, Total and Free, Serum (TFTEST).
Any additional information regarding these changes will be included in a future Technical Update.
If you have any questions about this change, please contact Client Services for assistance.
